Buffett plows money into GSK, Sanofi

Where Warren Buffett goes, others follow--and that's why anyone holding GlaxoSmithKline or Sanofi-Aventis options is smiling today. The billionaire investor's holding company told the Securities and Exchange Commission that it now owns 1.5 million of GSK's American Depository Receipts, valued at $76.1 million, and 3.6 million Sanofi ADRs, worth $162.5 million. GSK is already up 1.5 percent on the news.

- read the report from Forbes
- see more at Interactive Investor

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.